Pediatric Brain Tumor Market Share Trend, Insights, Overview Challenges, Segmentation and Forecast To 2027


The global pediatric brain tumor market is growing at the CAGR of 4.1% during the forecast period and expected to reach USD 1659.4 million by 2027., according to the latest research report from Market Research Future (MRFR).

.

Pediatric Brain Tumor Market Overview

The global pediatric brain tumor market is growing at the CAGR of 4.1% during the forecast period and expected to reach USD 1659.4 million by 2027., according to the latest research report from Market Research Future (MRFR). The global pediatric brain tumor market is mainly driven by the growing awareness about the disease and the increasing investment being made by government agencies in finding effective cures for the disease and the growing prevalence of pediatric brain cancer around the world.

the last few years. This is likely to be the main driver for the global pediatric brain tumor market over the forecast period, as the growing prevalence of the disease has raised awareness among parent demographics as well as mobilizing a steady stream of funding from government healthcare agencies to study and tackle the disease. The emotional factor behind pediatric brain cancer is also likely to play a key role in the growth of the global Pediatric Brain Tumor Market Share over the forecast period, as promotional campaigns for pediatric cancer often get more attention from governments and the general populace alike than campaigns focusing on adult cancer.

The growing healthcare infrastructure in the U.S., Germany, the UK, France, and other leading nations around the world, and the rising funding for clinical trials is likely to be a major driver for the global pediatric brain tumor market over the forecast period. Research efforts aimed at discovering definitive cures for pediatric cancer are likely to play a key role in the growth of the global pediatric brain tumor market over the forecast period, as the causality and progression mechanism of pediatric brain cancer is not understood in its entirety.

Pediatric Brain Tumor Market Segmentation

A better understanding of the global pediatric brain tumor market can be segmented on the basis of types, diagnosis, and treatment.

By type, the global pediatric brain tumor market can be segmented into mixed neuronal-glial tumors, gliomas, choroid plexus papilloma/carcinoma, embryonal tumors, meningeal tumors, tumors arising from non-neuroepithelial tissue, and others. The gliomas segment includes malignant gliomas, astrocytoma, and others. Mixed neuronal-glial tumors are segmented into pleomorphic xanthoastrocytoma, subependymal giant cell tumor, ganglioglioma, and others. Embryonal tumors segment encompasses primitive neuroectodermal tumor (PNET), atypical teratoid/rhabdoid tumor, and others. Tumors arising from non-neuroepithelial tissue includes pineal region tumors, craniopharyngioma, and others.

Based on the diagnosis, the global pediatric brain tumor market can be segmented into physical exam, Imaging tests, lumbar puncture (spinal tap), brain or spinal cord tumor biopsy, blood urine tests, and others. Imaging tests includes Computed Tomography (CT) scan, Magnetic Resonance Imaging (MRI) scan, Angiogram, Positron Emission Tomography (PET) scan, and others. Magnetic Resonance Imaging (MRI) scan comprises Magnetic Resonance Spectroscopy (MRS), Magnetic Resonance Angiography (MRA), Functional MRI (fMRI), Magnetic Resonance Perfusion, and others. Brain or spinal cord tumor biopsy can be studied better on the basis of craniotomy, stereotactic needle biopsy, and other.

By treatment, the pediatric brain tumor market has been studied on the basis of therapies, surgery, drug treatment, and others. Surgery segment includes resection (removal), shunt placement/revision, surgical biopsy, and others. Therapies segment has been studied with focus on chemotherapy, radiation therapy, targeted therapy, and others. Chemotherapy segment covers carboplatin, cisplatin, carmustine (BCNU), vincristine, etoposide, cyclophosphamide, methotrexate, lomustine (CCNU), thiotepa, temozolomide, and others. Drug treatment segment includes hormones, corticosteroids, anti-seizure drugs (anti-epileptics), and others. 

By end user, the pediatric brain tumor market consists hospitals clinics, medical research centers, academic institutes, and others.

Pediatric Brain Tumor Market Regional Analysis

By considering the pediatric brain tumor market on a region-specific level, MRFR included regions like North America, Europe, Asia Pacific (APAC), and the Rest-of-the-World (RoW). These segments are expected to thrive on various demographic features that can be studied to increase the profit margin in the coming years.

North America has the better market coverage and it can grow in the coming years with strong contributions made by the US and Canada. This is due to high level of awareness better market percolation of various industries, hike in healthcare expenditure, and various other factors. Europe is also in the line to earn revenues. The regional healthcare sector has similar market benefits like that of North America. In the APAC region, the market can depend on revamping healthcare sector, which can fetch in better revenues for the market.

Pediatric Brain Tumor Market Players

  • AbbVie Inc. (US)
  • (US)
  • Agios, Inc. (US)
  • Akorn, Inc. (US)
  • Bayer AG (US)
  • Baxter (US)
  • Novartis AG (Switzerland)
  • Epizyme, Inc. (US)
  • Mylan N.V. (US)

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/pediatric-brain-tumor-market-3690

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

 

Comments